These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11014244)

  • 21. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
    Rickard AJ; Funder JW; Morgan J; Fuller PJ; Young MJ
    Endocrinology; 2007 Oct; 148(10):4829-35. PubMed ID: 17640982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats.
    Ikeda H; Tsuruya K; Toyonaga J; Masutani K; Hayashida H; Hirakata H; Iida M
    Kidney Int; 2009 Jan; 75(2):147-55. PubMed ID: 18923385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
    López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
    Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
    Benter IF; Francis I; Cojocel C; Juggi JS; Yousif MH; Canatan H
    Auton Autacoid Pharmacol; 2005 Oct; 25(4):143-54. PubMed ID: 16176445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
    Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
    Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat.
    Ye VZ; Hodge G; Yong JL; Duggan KA
    Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
    Takemoto M; Egashira K; Usui M; Numaguchi K; Tomita H; Tsutsui H; Shimokawa H; Sueishi K; Takeshita A
    J Clin Invest; 1997 Jan; 99(2):278-87. PubMed ID: 9005996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
    Fiebeler A; Nussberger J; Shagdarsuren E; Rong S; Hilfenhaus G; Al-Saadi N; Dechend R; Wellner M; Meiners S; Maser-Gluth C; Jeng AY; Webb RL; Luft FC; Muller DN
    Circulation; 2005 Jun; 111(23):3087-94. PubMed ID: 15939810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
    Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
    Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP.
    Chander PN; Rocha R; Ranaudo J; Singh G; Zuckerman A; Stier CT
    J Am Soc Nephrol; 2003 Aug; 14(8):1990-7. PubMed ID: 12874452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
    Demeilliers B; Mimran A; Jover B
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S208-12. PubMed ID: 9892165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-arginine analogues inhibit aldosterone secretion in rats.
    Simmons JC; Freeman RH
    Am J Physiol; 1995 May; 268(5 Pt 2):R1137-42. PubMed ID: 7771573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II pressor response in the L-NAME-induced hypertensive pithed rat: role of the AT1 receptor.
    Figueroa-Guillén ES; Castro-Moreno P; Rivera-Jardón FF; Gallardo-Ortiz IA; Ibarra-Barajas M; Godínez-Hernández D
    Proc West Pharmacol Soc; 2009; 52():54-6. PubMed ID: 22128423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Mineralocorticoid Receptor Blockade and Statins on Kidney Injury Marker 1 (KIM-1) in Female Rats Receiving L-NAME and Angiotensin II.
    Huang J; Caliskan Guzelce E; Gholami SK; Gawelek KL; Mitchell RN; Pojoga LH; Romero JR; Williams GH; Adler GK
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation.
    Nishioka T; Suzuki M; Onishi K; Takakura N; Inada H; Yoshida T; Hiroe M; Imanaka-Yoshida K
    J Cardiovasc Pharmacol; 2007 May; 49(5):261-8. PubMed ID: 17513943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.
    Pojoga LH; Romero JR; Yao TM; Loutraris P; Ricchiuti V; Coutinho P; Guo C; Lapointe N; Stone JR; Adler GK; Williams GH
    Endocrinology; 2010 Mar; 151(3):1236-46. PubMed ID: 20097717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice.
    Nakano D; Lei B; Kitada K; Hitomi H; Kobori H; Mori H; Deguchi K; Masaki T; Minamino T; Nishiyama A
    Am J Hypertens; 2012 Mar; 25(3):354-8. PubMed ID: 22113172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II associated cardiac myocyte necrosis: role of adrenal catecholamines.
    Ratajska A; Campbell SE; Sun Y; Weber KT
    Cardiovasc Res; 1994 May; 28(5):684-90. PubMed ID: 8025914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of p38alpha MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury.
    Li Z; Ma JY; Kerr I; Chakravarty S; Dugar S; Schreiner G; Protter AA
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1972-7. PubMed ID: 16751295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.